LSE:INDV (Indivior PLC)
About INDV
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Indivior PLC (LSE: INDV) Latest News

Investing Articles
Here’s a cheap FTSE 250 growth stock I might buy for 2023

Investing Articles
Are these 3 cheap stocks to buy after the latest results?
Investing Articles
3 hot FTSE 250 shares that could surge in 2022

Investing Articles
3 FTSE 250 shares I would buy right now

Investing Articles
My best growth stocks to buy now with £5k
Investing Articles
Why did the Indivior share price rise 14% today?
Investing Articles
A cheap UK growth stock to buy right now
Investing Articles
Why this FTSE 250 stock doubled its share price in 2021
Investing Articles
3 FTSE 250 stocks I wish I’d bought in 2021
